Amber Bio
PrivateLast Round
Seed
Aug 3, 2023
Total Funding Raised
$26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Amber Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in August 2023.
Amber Bio is a biotechnology company that provides genetic medicine solutions through a proprietary RNA-writing gene-editing platform designed to address diverse genetic mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amber Bio Comparables
Compare Amber Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Therapeutics | 87% | |
| Ascidian Therapeutics | 85% | |
| EDIRNA, Inc. | 84% |
For institutional investors. Book with your work email.
Amber Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Amber Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| Playground Global | Seed |
| Pillar VC | Seed |
| Playground Global | Seed |
| Hummingbird Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 59% MoM.
- Aug 3, 2023
$26M round led by Andreessen Horowitz and Playground Global.
For institutional investors. Book with your work email.
Amber Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amber Bio's valuation, stock price, and market status.
Is Amber Bio a public or private company?
Amber Bio is a private company.
What is the current stock price of Amber Bio?
Amber Bio is a private company, so its shares have no public market price. Caplight tracks Amber Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amber Bio worth (valuation)?
Valuation information for Amber Bio is not publicly available.
Can I buy Amber Bio stock?
Amber Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amber Bio's last funding round?
Amber Bio's most recent funding round was Seed on August 3, 2023.
Who are the main investors in Amber Bio?
Key investors in Amber Bio include Andreessen Horowitz, Playground Global, Playground Global.
Will Amber Bio IPO soon?
No public IPO plans have been announced for Amber Bio.
How can I track Amber Bio secondary market activity?
Caplight tracks bids, offers, and trades in Amber Bio's shares on secondary markets.